ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,00%
Bitcoin
60.736,10
-0,10%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) Notícias

XGN

Exagen (XGN)

Exagen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:XGN
DataHoraFonteTítuloCódigoCompanhia
06/05/202417:05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
30/04/202417:05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
26/04/202409:30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
18/03/202409:00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
18/03/202408:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
08/03/202411:00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
07/03/202418:05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
06/03/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
14/02/202409:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
30/01/202418:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
08/01/202410:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
07/01/202414:00GlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
30/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
29/11/202319:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
27/11/202318:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
17/11/202318:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XGNExagen Inc
13/11/202319:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
13/11/202318:05GlobeNewswire Inc.Exagen Inc. Reports Strong Third Quarter 2023 ResultsNASDAQ:XGNExagen Inc
09/11/202318:05GlobeNewswire Inc.Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis BiomarkersNASDAQ:XGNExagen Inc
02/11/202317:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:XGNExagen Inc
30/10/202317:05GlobeNewswire Inc.Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023NASDAQ:XGNExagen Inc
17/10/202315:50Dow Jones NewsExagen Agrees to Pay Over $650K to Resolve Kickback AllegationsNASDAQ:XGNExagen Inc
28/09/202317:05GlobeNewswire Inc.Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual MeetingNASDAQ:XGNExagen Inc
12/09/202317:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:XGNExagen Inc
07/08/202309:00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2023 ResultsNASDAQ:XGNExagen Inc
26/07/202317:05GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:XGNExagen Inc
25/07/202317:05GlobeNewswire Inc.Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023NASDAQ:XGNExagen Inc
24/07/202317:05GlobeNewswire Inc.Exagen Inc. Appoints Paul Kim to Board of DirectorsNASDAQ:XGNExagen Inc
20/06/202317:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XGNExagen Inc
14/06/202317:51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XGNExagen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:XGN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
YDUQ3
ESTACIO PART ON
BOV
UNIP6
UNIPAR PNB
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados